Table 3 Stratified analysis of treatment modalities associated with stage I-IIA patients’ survival
Parametres | RT (−) | RT (+) | HR | P | ||
|---|---|---|---|---|---|---|
No. | MST(mo) | No. | MST(mo) | |||
LNM (−) | 34 | 80 | 12 | 39 | 3.363(1.245–10.619) | 0.018 |
LNM (+) | 15 | 43 | 7 | 47 | 0.581(0.157–2.157) | 0.571 |
DOI (≤2/3) | 9 | 25 | 6 | 35 | 0.486(0.087–2.706) | 0.410 |
DOI (> 2/3) | 40 | 71 | 13 | 43 | 2.338(0.906–6.035) | 0.079 |
≤4 cm | 28 | 76 | 10 | 39 | 0.371(0.115–1.195) | 0.097 |
> 4 cm | 21 | 59 | 9 | 44 | 1.363(0.464–4.139) | 0.560 |
LVSI(−) | 34 | 75 | 10 | 46 | 1.727(0.524–5.699) | 0.369 |
LVSI(+) | 15 | 51 | 9 | 36 | 1.385 (0.464–4.139) | 0.560 |
NACT(−) | NACT(+) | |||||
> 4 cm | 12 | 46 | 18 | 60 | 0.753(0.261–2.174) | 0.600 |